Evaluation of Whole Genome Sequencing and Software Tools for Drug Susceptibility Testing of Mycobacterium Tuberculosis

Clinical Microbiology and Infection - United Kingdom
doi 10.1016/j.cmi.2018.03.041
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Clinical Use of Whole Genome Sequencing for Mycobacterium Tuberculosis

BMC Medicine
Medicine
2016English

Whole Genome Sequencing Based Characterization of Extensively Drug-Resistant Mycobacterium Tuberculosis Isolates From Pakistan

PLoS ONE
Multidisciplinary
2015English

Resazurin Assay for Rapid Drug Susceptibility Testing of Mycobacterium Tuberculosis

Indian Journal of Microbiology Research
2018English

Mycobacterium Tuberculosis Next-Generation Whole Genome Sequencing: Opportunities and Challenges

Tuberculosis Research and Treatment
2018English

Towards Point-Of-Care Diagnosis of Pulmonary Tuberculosis and Drug Susceptibility Testing by Whole Genome Sequencing of DNA Isolated From Sputum

Canadian Journal of Biotechnology
2017English

Whole-Genome Sequencing of Mycobacterium Tuberculosis for Rapid Diagnostics: Feasibility of a Decentralised Model

Lancet Respiratory Medicine,The
PulmonaryRespiratory Medicine
2016English

Whole Genome Sequencing of Mycobacterium Tuberculosis Isolates and Clinical Outcomes of Patients Treated for Multidrug-Resistant Tuberculosis in Tanzania

BMC Genomics
BiotechnologyGenetics
2020English

Multicenter Evaluation of the MB/BACT System for Susceptibility Testing of Mycobacterium Tuberculosis

Journal of Clinical Microbiology
Microbiology
2004English

Susceptibility Testing of Mycobacterium Tuberculosis to Pyrazinamide

Journal of Medical Microbiology
MedicineMicrobiology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy